FDA Brief

Warning letters Drugs

FDA warning letter to

Marco Antonio Rodriguez Fierro

High riskIssued Mar 1, 2021Posted Mar 9, 2021Center for Drug Evaluation and Research | CDER

FDA found Marco Antonio Rodriguez Fierro’s hand sanitizer labeled 75% ethanol contained only 31% and was unapproved and misbranded.

What happened

FDA tested a batch of NATURAL GOLD GEL ALCOHOL ANTISEPTIC 75% Topical Solution that was detained and refused admission at the U.S. border; the product was labeled as made at this facility. The lab found only 31% v/v ethanol although the label stated 75% v/v. FDA also found the product was an unapproved new drug and misbranded, and it placed all of the firm’s drugs on Import Alert 66-78.

What FDA found

  1. The hand sanitizer was labeled as 75% ethanol but FDA testing found only 31% v/v ethanol.

    section 501(c), FD&C Act, 21 U.S.C. 351(c)
  2. The low ethanol level showed the firm’s quality assurance was not working under CGMP requirements.

    section 501(a)(2)(B), FD&C Act, 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer was an unapproved new drug sold without an FDA-approved application.

    section 505(a), FD&C Act, 21 U.S.C. 355(a); section 301(d), 21 U.S.C. 331(d)
  4. The label’s claim of 75% ethanol was false or misleading.

    section 502(a), FD&C Act, 21 U.S.C. 352(a)
  5. The product did not meet the conditions for marketing under section 505G and had no approved application.

    section 502(ee), FD&C Act, 21 U.S.C. 352(ee)

What FDA wants

FDA tells the firm to respond in writing within 15 working days with an investigation into the subpotency, a raw material and supplier list, all U.S.-shipped batches and reconciliation, and complete batch records; FDA also recommends a qualified CGMP consultant.

Who should pay attention

  • U.S. importers, distributors and retailers of hand sanitizer
  • brands that buy finished drug products from this Mexico-based manufacturer
  • consumers and health-care users relying on alcohol hand sanitizer

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Macau-Union Pharmaceutical Limited

    Macau-Union Pharmaceutical failed CGMP and sold unapproved, misbranded Bamboo Pharmacy OTC pain rubs in the U.S.

    High risk
  2. ImprimisRx NJ

    FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.

    High risk
  3. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  4. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk